Companies: 10,795·Total market cap: $144.5T
NeuroPace, Inc.

NeuroPace, Inc.

NPCENASDAQHealthcare● Active
$15.63
$-0.11(-0.70%)
Market Cap$532885234
P/E Ratio
52W High$19.6
52W Low$7.563

NeuroPace, Inc.(NPCE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NPCE · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$99.99M$79.91M$65.42M$45.52M$45.18M
Cost of Revenue$22.77M$20.82M$17.30M$13.03M$11.75M
Gross Profit$77.22M$59.09M$48.12M$32.49M$33.44M
Gross Margin %(computed)77.23%73.94%73.56%71.38%74.00%
Operating Expenses
R&D Expenses$27.89M$23.65M$20.78M$21.95M$18.21M
G&A Expenses$19.09M$17.43M$0.00M$0.00M$0.00M
Total Operating Expenses$93.56M$80.76M$75.30M$73.29M$57.17M
Operating Income($16.34M)($21.67M)($27.17M)($40.79M)($23.74M)
Operating Margin %(computed)-16.34%-27.12%-41.54%-89.62%-52.54%
Interest Income$2.82M$3.02M$3.05M$1.58M$0.45M
Interest Expense$7.46M$8.80M$8.52M$7.53M$7.41M
Income Before Tax($21.46M)($27.14M)($32.96M)($47.08M)($36.08M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($21.46M)($27.14M)($32.96M)($47.08M)($36.08M)
Net Margin %(computed)-21.47%-33.97%-50.38%-103.43%-79.85%
Per Share & EBITDA
EPS (Basic)$-0.66$-0.93$-1.27$-1.91$-2.17
Wtd Avg Shares32.72M29.13M25.85M24.59M16.61M
EBITDA($14.39M)($16.57M)($22.83M)($36.57M)($28.37M)
EBITDA Margin %(computed)-14.39%-20.74%-34.90%-80.33%-62.80%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解NeuroPace, Inc.

关于NeuroPace, Inc.(NPCE)损益表

NeuroPace, Inc.(NPCE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NPCE实现营收$0.10B,毛利润$0.08B(毛利率77.23%),净利润($0.02B)(净利率-21.47%)。

常见问题

NPCE · 4 问

NeuroPace, Inc.(NPCE)2025财年营收为$0.10B,同比up25.1%。

NPCE revenueNPCE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08